Orrick, Herrington & Sutcliffe LLP

Orrick, Herrington & Sutcliffe LLP has notable expertise at the intersection of life sciences and tech. The firm’s vast work comprises capital raising, M&A, IP counseling and litigation, licensing agreements, and product liability litigation. It is led by Los Angeles-based David Gindler, focusing on IP litigation and licensing, alongside co-heads Thora Johnson in Washington DC, concentrating on data privacy and health tech regulations, and Stephen Thau, a transactional matters specialist in New York. The team welcomed new partners, including New York patent litigator Irena Royzman, joining from HSF Kramer, and Boston’s David Sharrow from Gunderson Dettmer LLP, experienced in commercial transactions. The FDA and regulatory team grew with the addition of Georgia Ravitz, joining the DC team from Wilson Sonsini Goodrich & Rosati, Amy Joseph, and Jeremy Sherer; the latter two joined the Boston team from Hooper, Lundy & Bookman, PC.